Effective T-cell immune responses in the absence of the serine/threonine kinase RIP2

Microbes and Infection

Volumn 10, Issue 5, 2008, Pages 522-530

  Nembrini, Chiara ^a   Reissmann, Regina ^a   Kopf, Manfred ^a   Marsland, Benjamin J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Receptor interacting protein 2; T cell

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; PROTEIN KINASE RIP2; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; ENZYME MECHANISM; EX VIVO STUDY; HELPER CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; FLOW CYTOMETRY; INTERFERON TYPE II; LISTERIA INFECTIONS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

EID: 43649089648     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.01.016     Document Type: Article

References (29)

1. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P.L., and Littman D.R. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404 (2000) 402-407
2. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4 (2004) 348-359
3. Rawlings D.J., Sommer K., and Moreno-Garcia M.E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6 (2006) 799-812
4. Sun L., Deng L., Ea C.K., Xia Z.P., and Chen Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14 (2004) 289-301
5. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
6. Park J.H., Kim Y.G., McDonald C., Kanneganti T.D., Hasegawa M., Body-Malapel M., Inohara N., and Nunez G. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178 (2007) 2380-2386
7. Chin A.I., Dempsey P.W., Bruhn K., Miller J.F., Xu Y., and Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416 (2002) 190-194
8. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., and Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416 (2002) 194-199
9. Lu C., Wang A., Dorsch M., Tian J., Nagashima K., Coyle A.J., Jaffee B., Ocain T.D., and Xu Y. Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. J. Biol. Chem. 280 (2005) 16278-16283
10. Ruefli-Brasse A.A., Lee W.P., Hurst S., and Dixit V.M. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. J. Biol. Chem. 279 (2004) 1570-1574
11. McCarthy J.V., Ni J., and Dixit V.M. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J. Biol. Chem. 273 (1998) 16968-16975
12. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., and Kelliher M.A. NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2. J. Biol. Chem. 282 (2007) 36223-36229
13. Abbott D.W., Wilkins A., Asara J.M., and Cantley L.C. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14 (2004) 2217-2227
14. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., Ogura Y., and Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275 (2000) 27823-27831
15. Kim J.Y., Omori E., Matsumoto K., Nunez G., and Ninomiya-Tsuji J. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J. Biol. Chem. 283 (2008) 137-144
16. Windheim M., Lang C., Peggie M., Plater L.A., and Cohen P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem. J. 404 (2007) 179-190
17. Marsland B.J., Nembrini C., Grun K., Reissmann R., Kurrer M., Leipner C., and Kopf M. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J. Immunol. 178 (2007) 3466-3473
18. Marsland B.J., Nembrini C., Schmitz N., Abel B., Krautwald S., Bachmann M.F., and Kopf M. Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T-cell effector and memory responses. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14374-14379
19. Marsland B.J., Soos T.J., Spath G., Littman D.R., and Kopf M. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200 (2004) 181-189
20. Berg-Brown N.N., Gronski M.A., Jones R.G., Elford A.R., Deenick E.K., Odermatt B., Littman D.R., and Ohashi P.S. PKCtheta signals activation versus tolerance in vivo. J. Exp. Med. 199 (2004) 743-752
21. Bachmann M.F., Speiser D.E., Zakarian A., and Ohashi P.S. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism. Eur. J. Immunol. 28 (1998) 3110-3119
22. Storni T., and Bachmann M.F. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison. J. Immunol. 172 (2004) 6129-6135
23. Nembrini C., Abel B., Kopf M., and Marsland B.J. Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J. Immunol. 176 (2006) 7180-7188
24. Ruedl C., Bachmann M.F., and Kopf M. The antigen dose determines T helper subset development by regulation of CD40 ligand. Eur. J. Immunol. 30 (2000) 2056-2064
25. Oxenius A., Bachmann M.F., Zinkernagel R.M., and Hengartner H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28 (1998) 390-400
26. Boneca I.G., Dussurget O., Cabanes D., Nahori M.A., Sousa S., Lecuit M., Psylinakis E., Bouriotis V., Hugot J.P., Giovannini M., Coyle A., Bertin J., Namane A., Rousselle J.C., Cayet N., Prevost M.C., Balloy V., Chignard M., Philpott D.J., Cossart P., and Girardin S.E. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 997-1002
27. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., and Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
28. Hall H.T., Wilhelm M.T., Saibil S.D., Mak T.W., Flavell R.A., and Ohashi P.S. RIP2 contributes to Nod signaling but is not essential for T-cell proliferation, T helper differentiation or TLR responses. Eur. J. Immunol. 38 (2008) 64-72
29. Inohara N., del Peso L., Koseki T., Chen S., and Nunez G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273 (1998) 12296-12300